Literature DB >> 17892270

Magnetic relaxation switch detection of human chorionic gonadotrophin.

Grace Y Kim1, Lee Josephson, Robert Langer, Michael J Cima.   

Abstract

Functionalized nanoparticle contrast agents, also known as magnetic relaxation switches (MRS), were prepared to detect protein A and the beta subunit of human chorionic gonadotrophin (hCG-beta). Antibodies were attached to cross-linked iron oxide (CLIO) nanoparticles using standard peptide chemistry. Protein A was used as a simple model analyte, as it is naturally multivalent and can bind multiple CLIO-IgG simultaneously. The addition of PA to CLIO-IgG resulted in transverse relaxation time (T2) shortening compared to a blank control as seen by NMR relaxometry measurements. Analyte-induced aggregation was confirmed by light scattering particle size analysis. A two-particle system was designed to measure hCG-beta, as it is not multivalent and requires conjugation of a matched pair of monoclonal antibodies to CLIO (referred to as C95 and C97). Measurement of hCG-beta is important, as elevated serum levels are associated with malignancies including testicular and ovarian cancers. The addition of hCG-beta to C95 and C97 resulted in T2 shortening with a linear dynamic concentration range of 0.1 to 1 molecules of analyte per nanoparticle. Similar data were obtained for the hCG dimer. Observations with higher stoichiometric ratios of analyte to nanoparticle and increased nanoparticle valency were also made. This method can potentially be adapted to detect other biomarkers in solution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892270     DOI: 10.1021/bc070110w

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  14 in total

Review 1.  Magnetic nanoparticles in magnetic resonance imaging and diagnostics.

Authors:  Christine Rümenapp; Bernhard Gleich; Axel Haase
Journal:  Pharm Res       Date:  2012-03-06       Impact factor: 4.200

Review 2.  Multifunctional magnetic nanoparticles for targeted imaging and therapy.

Authors:  Jason R McCarthy; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

3.  Sensitive NMR sensors detect antibodies to influenza.

Authors:  Isaac Koh; Rui Hong; Ralph Weissleder; Lee Josephson
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

4.  Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers.

Authors:  Yibo Ling; Terrence Pong; Christophoros C Vassiliou; Paul L Huang; Michael J Cima
Journal:  Nat Biotechnol       Date:  2011-02-13       Impact factor: 54.908

Review 5.  Working principle and application of magnetic separation for biomedical diagnostic at high- and low-field gradients.

Authors:  Sim Siong Leong; Swee Pin Yeap; JitKang Lim
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

6.  Particles and microfluidics merged: perspectives of highly sensitive diagnostic detection.

Authors:  Tania Konry; Shyam Sundhar Bale; Abhinav Bhushan; Keyue Shen; Erkin Seker; Boris Polyak; Martin Yarmush
Journal:  Mikrochim Acta       Date:  2012-02       Impact factor: 5.833

7.  Mechanism of magnetic relaxation switching sensing.

Authors:  Changwook Min; Huilin Shao; Monty Liong; Tae-Jong Yoon; Ralph Weissleder; Hakho Lee
Journal:  ACS Nano       Date:  2012-07-10       Impact factor: 15.881

Review 8.  Current trends in nanobiosensor technology.

Authors:  Leon M Bellan; Diana Wu; Robert S Langer
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-03-09

9.  Implantable diagnostic device for cancer monitoring.

Authors:  Karen D Daniel; Grace Y Kim; Christophoros C Vassiliou; Marilyn Galindo; Alexander R Guimaraes; Ralph Weissleder; Al Charest; Robert Langer; Michael J Cima
Journal:  Biosens Bioelectron       Date:  2009-04-16       Impact factor: 10.618

10.  Nanoparticle-target interactions parallel antibody-protein interactions.

Authors:  Isaac Koh; Rui Hong; Ralph Weissleder; Lee Josephson
Journal:  Anal Chem       Date:  2009-05-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.